Effects on joint destruction and remission, bone turnover and lack of influence on atherogenesis: A review of the BARFOT low-dose prednisolone studies on patients with early RA

Clinical and Experimental Rheumatology

Volumn 29, Issue 5 SUPPL. 68, 2011, Pages

  Svensson, B ^a   Hafstrom I ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BARFOT study; Bone turnover; Early rheumatoid arthritis; Glucocorticoids; Prednisolone

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; PREDNISOLONE;

ARTICLE; ATHEROGENESIS; BONE DENSITY; FOLLOW UP; HUMAN; JOINT INJURY; JOINT RADIOGRAPHY; LOW DRUG DOSE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BONE REMODELING; GLUCOCORTICOIDS; HUMANS; JOINTS; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 81155144626     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. SVENSSON B, BOONEN A, ALBERTSSON K, VAN DER HEIJDE D, KELLER C, HAFSTRÖM I, for the BARFOT STUDY GROUP: Low dose prednisolone in addition to the initial DMARD in patients with early active rheumatoid arthritis reduces joint destruction and increases remission rate: a 2-year randomised trial. Arthritis Rheum 2005; 52: 3360-70. (Pubitemid 41612202)
2. HAFSTRÖM I, ALBERTSSON K, BOONEN A, VAN DER HEIJDE D, LANDEWÉ R, SVENSSON B: Remission achieved after 2 years treatment of early RA with low dose prednisolone in addition to DMARDs is associated with reduced joint destruction still after 4 years: an open two year continuation study. Ann Rheum Dis 2009; 68: 508-13.
3. ENGVALL IL, SVENSSON B, TENGSTRAND B, BRISMAR K, HAFSTRÖM I: Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis - Experiences from a two-year randomized study. Arthritis Res Ther 2008 Nov 5; 10: R128.
4. HAFSTRÖM I, ROHANI M, DENEBERG S, WÖRNERT M, JOGESTRAND T, FROSTEGÅRD J: Effects of low dose prednisolone on endothelial function, atherosclerosis and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis - a randomized study. J Rheumatol 2007; 34: 1810-6. (Pubitemid 350067638)
5. HENCH PS, KENDALL EC, SLOCUMB CH, POLLEY HF: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocortisone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report. Proc Staff Meet Mayoclin 1949; 24: 181-97.
6. JOINT COMMITTEE OF THE MEDICAL RESEARCH COUNCIL AND NUFFIELD FOUNDATION: A comparison of prednisolone with aspirin and other analgesics in the treatment of RA. Ann Rheum Dis 1959; 18: 173-87.
7. KIRWAN JR and the ARTHRITIS AND RHEUMATISM COUNCIL LOW-DOSE GLUCOCOR-TICOID STUDY GROUP: The effect of glucocorticoids on joint destruction in rheuma-toid arthritis. N Engl J Med 1995; 333: 142-6.
8. WASSENBERG S, RAU R, STEINFELD, ZEIDLER H, for the LOW-DOSE PREDNISOLONE THERAPY STUDY GROUP: Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years. Arthritis Rheum 2005; 52: 3371-80.
9. VAN EVERDINGEN AA, JACOBS JW, SIEWERTSZ VAN REESEMA DR, BIJLSMA JW: Low-dose prednisone therapy for patients with early active rheumatoid arthritis; clinical efficacy, disease-modifying properties and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002; 136: 1-12. (Pubitemid 34038692)
10. VAN DER HEIJDE DM, VAN LEEUWEN MA, VAN RIEL PL et al.: Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992; 35: 26-34.
11. PREVOO MLL, VAN GESTEL AM, VAN'T HOF MA, VAN RIJSWIJK MH, VAN DE PUTTE LBA, VAN RIEL PLCM: Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996; 35: 1101-5.
12. EKDAHL C, EBERHARDT K, ANDERSSON SI, SVENSSON B: Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988; 17: 263-71.
13. HICKLING P, JACOBY RK, KIRWAN JR and the ARTHRITIS AND RHEUMATISM COUNCIL LOW-DOSE GLUCOCORTICOID STUDY GROUP: Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol 1998; 37: 930-6.
14. LANDEWÉ RB, BOERS M, VERHOEVEN AC et al.: COBRA combination therapy in patients with early rheumatoid arthritis. Long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46: 347-56. (Pubitemid 34136571)